PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F103. A total of 13 filers reported holding PASITHEA THERAPEUTICS CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $59,293 | -1.3% | 121,007 | -24.5% | 0.00% | – |
| Q1 2023 | $60,073 | -41.6% | 160,195 | 0.0% | 0.00% | – |
| Q4 2022 | $102,797 | -48.9% | 160,195 | +0.2% | 0.00% | – |
| Q3 2022 | $201,000 | +154.4% | 159,844 | +104.6% | 0.00% | – |
| Q2 2022 | $79,000 | +6.8% | 78,139 | +38.1% | 0.00% | – |
| Q1 2022 | $74,000 | +236.4% | 56,583 | +345.5% | 0.00% | – |
| Q4 2021 | $22,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 282,437 | $181,240 | 0.03% |
| Virtu Financial LLC | 30,937 | $20 | 0.00% |
| VANGUARD GROUP INC | 160,195 | $102,797 | 0.00% |
| UBS Group AG | 12,732 | $8,148 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33 | $21 | 0.00% |
| WELLS FARGO & COMPANY/MN | 115 | $74 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 98,248 | $63 | 0.00% |
| STATE STREET CORP | 47,294 | $30,732 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,049 | $10 | 0.00% |